New testosterone spray could offer quick fix for low t

NCT ID NCT01894308

Not yet recruiting Disease control Sponsor: Transdermal Delivery Solutions Corp Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This phase 2 trial tests a new testosterone spray (HypoSpray) in 48 men with low testosterone. Participants receive one of four doses daily for 7 days. The goal is to measure how testosterone levels change and check for skin reactions. Results will guide future, longer studies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Testosterone

What this could lead to

If successful, this could lead to a more convenient testosterone replacement option for men with low testosterone.

What could go wrong

This is a small, early-phase study with only 48 participants and 7 days of treatment. It is designed to find the right dose, not to prove long-term safety or effectiveness. Skin reactions or ineffective dosing are possible.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates